Microsoft has been the quiet name in the Magnificent Seven for most of 2026. The stock lagged. The AI spending kept climbing. Investors kept waiting for the payoff. One Wall Street firm just said it Read more…
Intraday bias in EUR/JPY stays neutral as consolidations continue below 181.53. Risk of another rise remains as long as 177.82 holds. Firm break of 38.2% retracement of 187.93 to 181.68 will extend the rebound from Read more…
Outlook in EUR/GBP remains unchanged and intraday bias stays neutral. Strong resistance is still expected from 0.8610 to complete the corrective bounce from 0.8453. On the downside, break of 0.8551 support will turn bias back Read more…
This live blog is refreshed throughout the day with the latest updates from the market. To find the latest Stock Market Today threads, click here. Happy Friday. Stock futures edged higher and oil prices were lower as investors monitored a series of Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Now that summer is gone, you Read more…
While small airlines around the world are struggling with the sudden spike in jet fuel prices, the aviation industry in Russia is in a particularly poor state after the military invasion of Ukraine in February Read more…
GBP/USD fell to 1.3203 on Friday, marking a three-month low. The pound remains under pressure from a strong US dollar, expectations of further Federal Reserve rate hikes and a deteriorating economic outlook amid elevated oil Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal A nor’easter is heading toward the Read more…
The Australian Dollar is the week’s worst-performing major currency even with a September RBA hike to 4.60% essentially fully priced—the weakness reflects position lightening ahead of uncertain vote composition and guidance, not doubt about the Read more…
In May 1972, Ken Langone took over a tiny medical device company in San Diego through a proxy fight. The company had a market capitalization of $1.5 million. In Nov. 1977, Eli Lilly acquired it Read more…